Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

EPAM Systems Inc. (EPAM)

  • SEC News
  • Sept. 02, 2025, 20:15 UTC
  • 7
  • 1 comments

Yezhkov Sergey 🟡 adjusted position in 1.1K shares of EPAM Systems, Inc. (EPAM) at $174.18 Transaction Date: Apr 30, 2025 | Filing ID: 000010

Comment Full text

Plus Therapeutics Inc (PSTV)

  • Business News
  • Sept. 02, 2025, 20:15 UTC
  • 6
  • 0 comments

Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

Market reaction Comment Full text

EPAM Systems Inc. (EPAM)

  • SEC News
  • Sept. 02, 2025, 20:13 UTC
  • 6
  • 1 comments

Director Fejes Balazs 🟢 acquired 4.1K shares of EPAM Systems, Inc. (EPAM) Transaction Date: Sep 01, 2025 | Filing ID: 000009

Comment Full text

Doximity Inc (DOCS)

  • SEC News
  • Sept. 02, 2025, 20:12 UTC
  • 6
  • 0 comments

New Form 144 - Doximity, Inc. Filed: 2025-09-02 AccNo: 0001950047-25-006607 Size: 6 KB

Comment Full text

Alnylam Pharmaceuticals Inc (ALNY)

  • SEC News
  • Sept. 02, 2025, 20:10 UTC
  • 6
  • 1 comments

Tanguler Tolga 🔴 sold 3.5K shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) at $452.49 ($1.6M) Transaction Date: Aug 29, 2025 | Filing ID: 000094

Comment Full text

Fennec Pharmaceuticals Inc (FENC)

  • SEC News
  • Sept. 02, 2025, 20:10 UTC
  • 6
  • 1 comments

Raykov Rosty 🟢 acquired 5.2K shares of FENNEC PHARMACEUTICALS INC. (FENC) Transaction Date: Aug 31, 2025 | Filing ID: 023395

Comment Full text

Corcept Therapeutics Incorporated (CORT)

  • SEC News
  • Sept. 02, 2025, 20:09 UTC
  • 7
  • 0 comments

New Form 144 - CORCEPT THERAPEUTICS INC Filed: 2025-09-02 AccNo: 0001973251-25-000060 Size: 6 KB

Comment Full text

Amphastar (AMPH)

  • SEC News
  • Sept. 02, 2025, 20:09 UTC
  • 7
  • 0 comments

New Form 144 - Amphastar Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001969223-25-000696 Size: 6 KB

Comment Full text

Kala Pharmaceuticals Inc. (KALA)

  • SEC News
  • Sept. 02, 2025, 20:08 UTC
  • 7
  • 1 comments

Director Bazemore Todd 🟢 acquired 180.0K shares (1 derivative) of KALA BIO, Inc. (KALA) at $11.22 ($2.0M) Transaction Date: Aug 29, 2025 | Filing ID: 086367

Comment Full text

Boston Scientific Corp (BSX)

  • SEC News
  • Sept. 02, 2025, 20:08 UTC
  • 8
  • 0 comments

New Form 144 - BOSTON SCIENTIFIC CORP Filed: 2025-09-02 AccNo: 0001950047-25-006601 Size: 6 KB

Comment Full text

United Therapeutics Corporation (UTHR)

  • SEC News
  • Sept. 02, 2025, 20:08 UTC
  • 8
  • 0 comments

New Form 144 - UNITED THERAPEUTICS Corp Filed: 2025-09-02 AccNo: 0001950047-25-006600 Size: 4 KB

Comment Full text

Doximity Inc (DOCS)

  • SEC News
  • Sept. 02, 2025, 20:08 UTC
  • 7
  • 0 comments

New Form 144 - Doximity, Inc. Filed: 2025-09-02 AccNo: 0001950047-25-006599 Size: 6 KB

Comment Full text

Incyte Corporation (INCY)

  • SEC News
  • Sept. 02, 2025, 20:07 UTC
  • 6
  • 0 comments

New Form 144 - INCYTE CORP Filed: 2025-09-02 AccNo: 0001950047-25-006598 Size: 9 KB

Comment Full text

Health Catalyst Inc (HCAT)

  • SEC News
  • Sept. 02, 2025, 20:07 UTC
  • 4
  • 0 comments

New Form 144 - Health Catalyst, Inc. Filed: 2025-09-02 AccNo: 0001636422-25-000129 Size: 4 KB

Comment Full text

Puma Biotechnology Inc (PBYI)

  • Business News
  • Sept. 02, 2025, 20:07 UTC
  • 4
  • 0 comments

Puma Biotechnology, Inc. - Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Market reaction Comment Full text
  • Previous
  • 365
  • 366
  • 367
  • 368
  • 369
  • Next

Search

News categories

  • Technical Exchange News(10123)
  • Event(419)
  • SEC News(171049)
  • FDA Approval(9498)
  • Company Report(721)
  • Business News(114052)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin